Patch testing is an effective method for the diagnosis of carbamazepine‐induced drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome in an 8‐year‐old girl
Authors:
- 24 April 2012
- journal article
- case report
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 53 (4) , 274-277
Abstract
Drug reaction, eosinophilia and systemic symptoms (DRESS) is an acute and life‐threatening disease, characterised by fever, rash and systemic symptoms, including lymphadenopathy, abnormal liver function, interstitial nephritis, pulmonary and cardiac infiltrates and haematological abnormalities with eosinophilia and atypical lymphocytes. The drugs mostly associated with DRESS are anticonvulsants, allopurinol, minocycline and sulfonamides. This syndrome is rarely seen in childhood even though a large number of children have anticonvulsant treatment. An 8‐year‐old girl was admitted with fever, lymphadenopathy and skin eruptions on her trunk. Her medical history was notable for epilepsy and carbamazepine treatment had been started 5 weeks previously. Laboratory studies showed a white cell count of 6200/µL (normal, 4100–11 200/µL) with 22% eosinophils and a γ‐glutamyl transpeptidase level of 296 U/L (normal, 0–23 U/L). Laboratory tests for infections and collagen diseases were in the normal range. Persistence of fever and maculopapular eruption with generalised desquamation and the appearance of cheilitis and facial angioedema suggested a hypersensitivity reaction to carbamazepine. The carbamazepine was replaced with levetiracetam. All clinical symptoms improved within a week with corticosteroids and antihistamine treatment. Six weeks after complete recovery an epicutaneous patch test with carbamazepine was performed and a carbamazepine‐induced positive skin reaction was observed at 48‐h. Carbamazepine‐induced DRESS syndrome is a rare entity in children. An epicutaneous patch test is a useful tool for identifying the inducing agent for the DRESS syndrome and for identifying a safe anticonvulsant drug.Keywords
This publication has 14 references indexed in Scilit:
- Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS)Contact Dermatitis, 2010
- Patch-tests medicamenteux dans l’exploration des toxidermiesAnnales de Dermatologie et de Vénéréologie, 2009
- Skin Testing in Delayed Reactions to DrugsImmunology and Allergy Clinics of North America, 2009
- The Variable Clinical Picture of Drug-Induced Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms in Relation to the Eliciting DrugImmunology and Allergy Clinics of North America, 2009
- Patch Testing for the Diagnosis of Anticonvulsant Hypersensitivity SyndromeDrug Safety, 2009
- Drug-induced Hypersensitivity Syndrome(DIHS): A Reaction Induced by a Complex Interplay among Herpesviruses and Antiviral and Antidrug Immune ResponsesAllergology International, 2006
- Guidelines for performing skin tests withdrugs in the investigation of cutaneous adverse drug reactionsContact Dermatitis, 2001
- Anticonvulsant Hypersensitivity SyndromeDrug Safety, 1999
- The use of skin testing in the investigation of cutaneous adverse drug reactionsBritish Journal of Dermatology, 1998
- Patch testing in severe cutaneous adverse drug reactions, including Stevens‐Johnson syndrome and toxic epidermal necrolysisContact Dermatitis, 1996